Long-term foscarnet therapy not associated with the development of foscarnet-resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patient.
Tachedjian G, Hoy J, McGavin K, Birch C
Cellular topoisomerase I activity associated with HIV-1.
Jardine D, Tachedjian G, Locarnini S, Birch C
Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
Birch CJ, Tyssen DP, Tachedjian G, Doherty R, Hayes K, Mijch A, Lucas CR
Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.
Civitico G, Wang YY, Luscombe C, Bishop N, Tachedjian G, Gust I, Locarnini S
Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Birch CJ, Tachedjian G, Doherty RR, Hayes K, Gust ID
Diethanolamine fusidate has no in-vitro activity against the human immunodeficiency virus.